A new market study by Grand View Research, Inc. of San Francisco, CA estimates the value of the world vaccine market at $32.5 billion in 2015. The study forecasts the market to grow to $77.5 billion by 2024. Grand View Research attributes the growth mainly to the “rising demand for better healthcare infrastructure and high awareness levels of the benefits of immunization.”1 2
The research firm observes that vaccination coverage has been steadily increasing around the world. The company specifically cites the Diphtheria, Pertussis, and Tetanus vaccine, or “DPT3”, as an example.
For instance, in 2014, 115 million infants across the world received the Diphtheria, Pertussis, and Tetanus (DPT3) vaccine and around 129 countries globally have achieved nearly 90% vaccination coverage for DPT3.2
Inactivated vaccines are projected to dominate the market due, in part, to their “long-shelf life” and “high stability,” while DNA vaccine development is forecast to experience the fastest growth rate, allegedly due to to the “high specificity” and the “reduced risk of integration into the genome as compared to other traditional vaccines.”2
Another factor for growth in the market is simply the sheer volume of new vaccines under development for a wide range of diseases. Among the more than 270 vaccines in the pipeline3 is the Herpes Zoster Subunit (HZ/su)—“a recombinant version” of the Shingles vaccine.”2
According to the study, the global vaccine market is divided up into four major segments: infectious diseases, cancer, allergy, and autism. The largest of these is infectious diseases. The study notes the “rising incidences” of “severe” diseases, including chicken pox, cholera, hepatitis, measles, and typhoid, with new vaccine research and development also focusing “fatal” diseases such as AIDS, Chagas, Ebola, Hepatitis C, Leishmaniasis, norovirus, and paratyphoid fever.”2
North America represents the largest market for vaccines in terms of revenue. Grand View Research estimates the region will generate more than $27 billion in vaccine sales revenue by 2024. The Asia-Pacific region, however, is considered to have the fastest market growth potential because of its “emerging economies” and its growing “target population base with high-unmet clinical needs.”2
Major vaccine manufacturers mentioned in the study include CSL of Australia; AstraZeneca and GlaxoSmithKline of the United Kingdom; Janssen Pharmaceuticals of Belgium; Novartis of Switzerland; Sanofi Pasteur of France; Takeda Pharmaceuticals of Japan; Valeant Pharmaceuticals of Canada; and Abbott Laboratories, Emergent BioSolutions, Johnson and Johnson, Merck and Pfizer of the United States.”2
A study published earlier this year by Kalorama Information, LLC of Rockville, MD projected the global vaccine market to be worth $45.1 billion by 2022.4 Another similar study last year by Markets and Markets, Inc. of Vancouver, WA estimated the vaccine market would grow to $57.8 billion by 2019 and $100 billion by 2025.5
1 Vaccine Market Size Projected To Reach $77.5 Billion By 2024: Grand View Research, Inc. CBS News 8 Aug. 8, 2016.
2 Vaccine Market Analysis By Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, DNA Vaccines), By Application (Infectious Diseases, Cancer, Autism, Allergy) And Segment Forecasts to 2024. Grand View Research August 2016.
3 La Vigne P. Pharmaceutical Companies Developing 270 New Vaccines. The Vaccine Reaction June 21, 2015.
4 TVR Staff. Study: World Vaccine Market Will Be Worth $45.1 Billion by 2022. The Vaccine Reaction June 8, 2016.
5 Cáceres M. Merck Leads World’s Top Vaccine Makers, Novartis Out. The Vaccine Reaction Aug. 28, 2015.
There needs to be more research on the short and long term effects of getting so many different vaccines. Some exercise only part of the immune system, leaving you more prone to cancer later in life (I’ve read but have not verified). And adjuvants and preservatives have some toxicity. Aluminum, thimerisol are some. And oil based adjuvants (squalene etc) may be causing autoimmune diseases. I’d rather just have a strong immune system that will survive the intruder w/o major symptoms. I think there should be more research in this area.
Perhaps if we stop inviting some of these diseases into the country we would need less vaccinations.
Yes, let’s just close our borders to anyone visiting from another country. That’s realistic.
Just saddens me to see how many have fallen for the inaccurate studies, etc…..
And will allow these poisons to invade their children.
Makes me cry……
“…due to the high awareness levels of the benefits of immunization.” HA! More like relentless fear mongering propaganda campaign.
I appreciate NVIC sharing this study about the extremely profitable vaccine program. We hear repeatedly that the pharmaceutical industry is not actually making that much money on vaccines so greed couldn’t possibly be a motive for them pushing the CDC to mandate the vaccine schedule and to falsify studies and to bride public health officials and legislators. Now we know they do all this because it’s very good for business.
Well of course it will! They continue to create more and more and more vaccines, for illnesses which most of us will never come into contact with, then the government MANDATES that we get them and the pharmaceutical companies that make them are held harmless from any resulting deaths or injuries. The pharmaceutical companies, CDC, FDA, and individual doctors all get to line their pockets with blood money.
OK. Now I want to see the real monetary costs of all the vaccine injuries that the rest of us pick up and deal with. Of course, that doesn’t even begin to cover the lost productivity from the injured and their families who stop having children, drop out of the work place to care for the injured, the lost family income, the extra costs of the disease to the family, the destruction of the family’s health, the destruction of some families, and on and on we go.